| scholarly article | Q13442814 |
| P2093 | author name string | In-Kyu Lee | |
| Mi-Kyung Kim | |||
| Keun-Gyu Park | |||
| Gwon-Soo Jung | |||
| Hye-Soon Kim | |||
| Jung-Guk Kim | |||
| Yun-A Jung | |||
| Ki-Up Lee | |||
| In-Sun Park | |||
| Bon-Hong Min | |||
| P2860 | cites work | Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta | Q38331875 |
| A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis | Q39793286 | ||
| Activin A is a potent activator of renal interstitial fibroblasts | Q40604314 | ||
| Synthesis and functional analyses of nuclear clusterin, a cell death protein | Q40674770 | ||
| Clusterin protects against oxidative stress in vitro through aggregative and nonaggregative properties | Q41038445 | ||
| Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury | Q43067030 | ||
| Clusterin protects renal tubular epithelial cells from gentamicin-mediated cytotoxicity | Q43906902 | ||
| Modulation of different clusterin isoforms in human colon tumorigenesis | Q44750584 | ||
| Blockade of TGF-beta action ameliorates renal dysfunction and histologic progression in anti-GBM nephritis. | Q45862669 | ||
| Bone marrow mononuclear cells attenuate interstitial fibrosis and stimulate the repair of tubular epithelial cells after unilateral ureteral obstruction | Q46310557 | ||
| Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy | Q46393305 | ||
| TGF-beta1 siRNA suppresses the tubulointerstitial fibrosis in the kidney of ureteral obstruction | Q46916569 | ||
| Multifunctionality of PAI-1 in fibrogenesis: evidence from obstructive nephropathy in PAI-1-overexpressing mice. | Q50766818 | ||
| Protective role of clusterin/apolipoprotein J against neointimal hyperplasia via antiproliferative effect on vascular smooth muscle cells and cytoprotective effect on endothelial cells. | Q53499214 | ||
| Plasmin(ogen) Promotes Renal Interstitial Fibrosis by Promoting Epithelial-to-Mesenchymal Transition: Role of Plasmin-Activated Signals | Q57741352 | ||
| PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction | Q57741393 | ||
| Clusterin is up-regulated in glomerular mesangial cells in complement-mediated injury | Q73338471 | ||
| The renal expression of transforming growth factor-beta isoforms and their receptors in acute and chronic experimental diabetes in rats | Q73500725 | ||
| Molecular pathological evaluation of clusterin in a rat model of unilateral ureteral obstruction as a possible biomarker of nephrotoxicity | Q80206977 | ||
| Quantitative gene expression analysis in a nonhuman primate model of antibiotic-induced nephrotoxicity | Q80794194 | ||
| Plasminogen activator inhibitor-1 gene deficiency attenuates TGF-beta1-induced kidney disease | Q81549378 | ||
| Clusterin, a novel modulator of TGF-beta signaling, is involved in Smad2/3 stability | Q28261241 | ||
| Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy | Q30448126 | ||
| Apolipoprotein J/clusterin limits the severity of murine autoimmune myocarditis | Q30532828 | ||
| Evaluation of novel biomarkers of nephrotoxicity in two strains of rat treated with Cisplatin | Q33661304 | ||
| Plasminogen activator inhibitor 1: physiological and pathophysiological roles. | Q33958024 | ||
| Transforming growth factor-beta signal transduction and progressive renal disease | Q33963170 | ||
| HSP72 attenuates renal tubular cell apoptosis and interstitial fibrosis in obstructive nephropathy. | Q33976494 | ||
| Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis | Q34067658 | ||
| Clusterin/apolipoprotein J in human aging and cancer | Q34146411 | ||
| Apolipoprotein J/clusterin prevents a progressive glomerulopathy of aging | Q34323718 | ||
| Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation | Q34527773 | ||
| Clusterin protects H9c2 cardiomyocytes from oxidative stress-induced apoptosis via Akt/GSK-3β signaling pathway | Q34587120 | ||
| Obstructive nephropathy and renal fibrosis | Q34953429 | ||
| Pathogenesis of fibrosis: role of TGF-beta and CTGF. | Q34985703 | ||
| Reactive oxygen species and matrix remodeling in diabetic kidney | Q35182366 | ||
| Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up | Q35590527 | ||
| Mammalian transforming growth factor-betas: Smad signaling and physio-pathological roles. | Q35756439 | ||
| Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse | Q35842105 | ||
| Clusterin and Alzheimer's disease. | Q36040356 | ||
| Mediators of fibrosis and apoptosis in obstructive uropathies | Q36046140 | ||
| Evidence that inhibition of tubular cell apoptosis protects against renal damage and development of fibrosis following ureteric obstruction | Q36337198 | ||
| A PAI-1 mutant, PAI-1R, slows progression of diabetic nephropathy | Q36677370 | ||
| Interaction of transforming growth factor beta receptors with apolipoprotein J/clusterin | Q36790404 | ||
| PAI-1 and kidney fibrosis | Q36846526 | ||
| PAI-1 as a target in kidney disease | Q36952115 | ||
| Induction of clusterin by AKT--role in cytoprotection against docetaxel in prostate tumor cells | Q37418683 | ||
| Chapter 9: Oxidative stress in malignant progression: The role of Clusterin, a sensitive cellular biosensor of free radicals | Q37624996 | ||
| TGF-beta1-induced epithelial-to-mesenchymal transition and therapeutic intervention in diabetic nephropathy. | Q37627056 | ||
| Assessment of cisplatin-induced nephrotoxicity by microarray technology | Q38296612 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 73-85 | |
| P577 | publication date | 2011-11-03 | |
| P1433 | published in | Journal of the American Society of Nephrology | Q17123893 |
| P1476 | title | Clusterin attenuates the development of renal fibrosis | |
| P478 | volume | 23 |
| Q33941969 | Antifibrotic effects of KS370G, a caffeamide derivative, in renal ischemia-reperfusion injured mice and renal tubular epithelial cells. |
| Q83227242 | Brain clusterin protein isoforms and mitochondrial localization |
| Q38872845 | Calcium oxalate calculi-induced clusterin expression in kidney |
| Q34078756 | Clusterin/apolipoprotein J attenuates angiotensin II-induced renal fibrosis |
| Q35027749 | Comparative transcriptional profiling of 3 murine models of SLE nephritis reveals both unique and shared regulatory networks |
| Q35907575 | Comparative transcriptional profiling of renal cortex in rats with inherited stress-induced arterial hypertension and normotensive Wistar Albino Glaxo rats |
| Q50877034 | DNA base-stacking assay utilizing catalytic hairpin assembly-induced gold nanoparticle aggregation for colorimetric protein sensing. |
| Q35903097 | Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides |
| Q34441024 | Dimethylfumarate attenuates renal fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling |
| Q104073661 | Discovery of a novel fibroblast activation protein (FAP) inhibitor, BR103354, with anti-diabetic and anti-steatotic effects |
| Q47643373 | Diverse functions of clusterin promote and protect against the development of pulmonary fibrosis. |
| Q27005788 | Epigenetics of progression of chronic kidney disease: fact or fantasy? |
| Q92406555 | Gemigliptin Attenuates Renal Fibrosis Through Down-Regulation of the NLRP3 Inflammasome |
| Q99350177 | Glomerular clusterin expression is increased in diabetic nephropathy and protects against oxidative stress-induced apoptosis in podocytes |
| Q36760362 | Identification of the thiol isomerase-binding peptide, mastoparan, as a novel inhibitor of shear-induced transforming growth factor β1 (TGF-β1) activation |
| Q37723232 | Lobeglitazone, a Novel Peroxisome Proliferator-Activated Receptor γ Agonist, Attenuates Renal Fibrosis Caused by Unilateral Ureteral Obstruction in Mice |
| Q92940908 | Measurements of echocardiographic indices and biomarkers of kidney injury in dogs with chronic kidney disease |
| Q33901411 | Performance of urinary neutrophil gelatinase-associated lipocalin, clusterin, and cystatin C in predicting diabetic kidney disease and diabetic microalbuminuria: a consecutive cohort study |
| Q36138680 | Relationship of clusterin with renal inflammation and fibrosis after the recovery phase of ischemia-reperfusion injury |
| Q37056839 | Renoprotective Effect of Gemigliptin, a Dipeptidyl Peptidase-4 Inhibitor, in Streptozotocin-Induced Type 1 Diabetic Mice. |
| Q38670777 | The CLU-files: disentanglement of a mystery |
| Q38149803 | The physiological roles of apolipoprotein J/clusterin in metabolic and cardiovascular diseases |
| Q55231491 | Urinary Clusterin Is Upregulated in Nephropathia Epidemica. |
| Q40964596 | Urinary biomarkers of chronic allograft nephropathy. |
| Q39966934 | X-Linked Hereditary Nephropathy in Navasota Dogs: Clinical Pathology, Morphology, and Gene Expression During Disease Progression. |
Search more.